Volgende

Automatisch afspelen

MRD’s Potential Role in Treating Acute Myeloid Leukemia

0 Bekeken • 07/04/23
Delen
insluiten
administrator
administrator
abonnees
0

Harry Erba, MD, PhD; Alexander E. Perl, MD; Eunice Wang, MD; and Jorge E. Cortes, MD, debate the current value of minimal residual disease testing for therapeutic decision-making in acute myeloid leukemia and identify the needs to be addressed before use in standard practice.

Laat meer zien
0 Comments sort Sorteer op
Facebook Reacties

Volgende

Automatisch afspelen